文献速递腹部介入USCTMR

对比增强超声对融合成像引导下不可见局灶性肝脏病变活检的附加价值

Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance.
PubMed 文献 · Korean J Radiol · 2017-01-05

该回顾性研究纳入2013年6月至2015年1月间711例超声引导下经皮肝病灶活检中16例(2.3%)融合成像不可见病灶,评估加用Sonazoid对比增强超声(CEUS)后病灶可见性及活检可行性。结果显示CEUS后15/16(93.8%)病灶可见,清晰度评分显著提高(p<0.001),活检技术成功率87.6%(14/16),11/16(68.8%)患者临床决策发生改变。结论认为加用CEUS可提高融合成像不可见肝病灶的清晰度,并可能通过改变临床决策影响患者管理。

要点

  • 融合成像不可见的肝病灶加用Sonazoid CEUS后93.8%(15/16)可显示。
  • CEUS后病灶清晰度评分较融合成像显著提高(p<0.001)。
  • 加用CEUS引导活检技术成功率87.6%(14/16),68.8%(11/16)患者临床决策改变。

核心结论

  • 加用CEUS可提高融合成像不可见局灶性肝脏病变的清晰度,这种CEUS与融合成像的双重引导可能通过改变临床决策影响患者管理。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准,2013年6月至2015年1月共711例超声引导下经皮局灶性肝脏病变活检,其中16例(2.3%)融合成像不可见病灶纳入研究并使用CEUS引导活检,参考标准为组织病理学结果。

关键影像表现/征象

  • 术前影像目标病灶中位大小1.1 cm(范围0.5-1.9 cm)。
  • 加用CEUS后16个病灶中15个(93.8%)可见。
  • 加用CEUS后病灶清晰度评分较融合成像显著提高(p<0.001)。

诊断标准与关键数值

  • 病灶清晰度采用4分评分法评估,加用CEUS后评分较融合成像显著提高(p<0.001)。
  • 活检技术成功率为87.6%(14/16),基于组织病理学结果判定。

临床应用与阅片要点

  • 对于融合成像上不可见的局灶性肝脏病变,可加用Sonazoid CEUS引导以提高病灶显示和活检可行性。
  • 加用CEUS后68.8%(11/16)患者临床决策发生改变,提示该技术可能影响患者管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess whether contrast-enhanced ultrasonography (CEUS) with Sonazoid can improve the lesion conspicuity and feasibility of percutaneous biopsies for focal hepatic lesions invisible on fusion imaging of real-time ultrasonography (US) with computed tomography/magnetic resonance images, and evaluate its impact on clinical decision making.

MATERIALS AND METHODS: The Institutional Review Board approved this retrospective study. Between June 2013 and January 2015, 711 US-guided percutaneous biopsies were performed for focal hepatic lesions. Biopsies were performed using CEUS for guidance if lesions were invisible on fusion imaging. We retrospectively evaluated the number of target lesions initially invisible on fusion imaging that became visible after applying CEUS, using a 4-point scale. Technical success rates of biopsies were evaluated based on histopathological results. In addition, the occurrence of changes in clinical decision making was assessed.

RESULTS: Among 711 patients, 16 patients (2.3%) were included in the study. The median size of target lesions was 1.1 cm (range, 0.5-1.9 cm) in pre-procedural imaging. After CEUS, 15 of 16 (93.8%) focal hepatic lesions were visualized. The conspicuity score was significantly increased after adding CEUS, as compared to that on fusion imaging (p < 0.001). The technical success rate of biopsy was 87.6% (14/16). After biopsy, there were changes in clinical decision making for 11 of 16 patients (68.8%).

CONCLUSION: The addition of CEUS could improve the conspicuity of focal hepatic lesions invisible on fusion imaging. This dual guidance using CEUS and fusion imaging may affect patient management via changes in clinical decision-making.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Kang TW, Lee MW, Song KD, et al. Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance. Korean J Radiol. 2017. PMID: 28096725. doi:10.3348/kjr.2017.18.1.152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。